HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$8.84
Day range
$8.60 - $9.19
Year range
$8.06 - $18.75
Market cap
118.80M USD
Avg Volume
105.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.08M | 185.05% |
Net income | -8.04M | -192.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.08M | -185.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.09M | -41.45% |
Total assets | 4.09M | -41.47% |
Total liabilities | 1.56M | 429.79% |
Total equity | 2.53M | — |
Shares outstanding | 13.27M | — |
Price to book | 46.53 | — |
Return on assets | -407.52% | — |
Return on capital | -537.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -8.04M | -192.72% |
Cash from operations | -1.85M | 14.02% |
Cash from investing | — | — |
Cash from financing | 121.83K | — |
Net change in cash | -1.73M | 19.67% |
Free cash flow | 1.14M | 196.22% |
About
Founded
2006
Headquarters
Website
Employees
6
